WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:EGRX) today announced that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at two upcoming conferences as follows:
At the Jefferies 2016 Healthcare Conference, Eagle’s presentation is scheduled as follows:
|Date:||June 8, 2016|
|Time:||2:00 p.m. Eastern Time|
At the William Blair 36th Annual Growth Stock Conference, Eagle’s presentation is scheduled as follows:
|Date:||June 16, 2016|
|Time:||12:20 p.m. Eastern Time/11:20 a.m. Central Time|
|Location:||Four Seasons, Chicago|
The presentations will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.